Press Releases
PCMA Statement On House Energy And Commerce Markup
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on today’s markup in the U.S. House
PCMA Releases New Policy Recommendations to Remove Barriers to Biosimilars, Lower Drug Costs
(Washington, D.C.) — Pharmacy benefit managers, PBMs, support the proliferation and use of biosimilars. A robust biosimilar market will increase competition
Test
testaksdj;flkajsd;lfhasldkfj;aslkjfa;ksdj a;lskdjla;skdjfl;aksjdfl;akjsd;lfkajsd;lk
PCMA Statement on COVID-19
As the Pharmaceutical Care Management Association (PCMA) closely monitors the COVID-19 outbreak, our industry’s priority is that Americans have ready
PCMA Statement on Drug Pricing in President Trump’s State of the Union Address
In his State of the Union address Tuesday night, President Donald Trump spoke about the need to lower drug prices
New Survey Shows Employers Overwhelmingly Satisfied with PBMs
Employers report high satisfaction with drug savings PBMs get and the transparency they provide (Washington, D.C.) — A new survey released
Independent Pharmacies Increase in 2026
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) released new data that provides a snapshot of the health of
PBM Reform is Done… Now What?
MEMORANDUM To: Interested Parties From: Brendan Buck, PCMA Re: PBM Reform is Done… Now What? Date: February 3, 2026 Today’s the
